Transient granulocytopenia develops during the first few minutes of hemodialysis, and is associated with a marked increase in granulocyte adherence as the cells marginate in the pulmonary circulation. The increased adherence is mediated by factors present in the plasma, thought to be complement components activated by the dialysis coil. In the present study, an assay of plasma for adherence-augmenting activity shows that it is maximal at 15 min after starting dialysis, and undetectable at 40 min. The factor is not affected by heating to 56 °C for 30 min, or by incubation at 37°C for 7 days, nor does dialysis for 24 h against physiologic saline diminish its activity. However, exposure to pH 6.0 reduces the activity to 58.4% of control, and pH 5.0 reduces it to 40.1%. Finally, pretreatment of patients with prednisone before hemodialysis does not prevent granulocytopenia or increased adherence. These findings are discussed in relation to the known properties of various biologically active fragments of complement.

Keywords:
Granulocytopenia, Hemodialysis, Complement
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.